CJC-1295 + Ipamorelin (GHRH Analog + Ghrelin Receptor Peptide)
CJC-1295 and Ipamorelin are synthetic peptides referenced in scientific literature for their interaction with growth hormone–releasing hormone (GHRH) receptors and ghrelin receptor signaling pathways. This combination is utilized in laboratory research exploring growth hormone axis regulation and peptide-mediated endocrine signaling mechanisms.
In controlled experimental environments, the CJC + Ipamorelin combination has been examined in studies involving:
• GHRH receptor signaling pathway research
• Ghrelin receptor interaction models
• Regulation of endogenous growth hormone release mechanisms
• IGF-1 signaling cascade studies
• Peptide influence on hypothalamic–pituitary axis pathway models
Because these peptides interact with complementary hormonal signaling pathways, they are frequently used in endocrine and cellular signaling research investigating how peptide agonists influence growth hormone regulatory networks.
Atlas Compounds supplies CJC-1295 + Ipamorelin as a 10 mg peptide blend in powder form, verified at ≥99% purity by HPLC analysis.
This material is intended strictly for laboratory research and analytical applications.
Packaging Options
Peptide Vial
• Contains the CJC-1295 + Ipamorelin blend in powder form
• Sealed vial for research handling and storage
Peptide Vial + Bacteriostatic Water
• Includes the peptide vial and a separate vial of bacteriostatic water
• Provided for general solution preparation where applicable